1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Orthopedics Market Trends
  5. > Australia Orthobiologics Market Outlook to 2021

Australia Orthobiologics Market Outlook to 2021

  • September 2015
  • -
  • Global Data
  • -
  • 45 pages

Australia Orthobiologics Market Outlook to 2021

Summary

GlobalData’s new report, "Australia Orthobiologics Market Outlook to 2021", provides key market data on the Australia Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market segments - Bone Graft and Substitutes, Viscosupplementation and Bone Growth Stimulators.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Orthobiologics market categories - Bone Graft and Substitutes, Viscosupplementation and Bone Growth Stimulators.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Orthobiologics market.
- Global corporate-level profiles of key companies operating within the Australia Orthobiologics market.
- Key players covered include DePuy Companies, Sanofi, Medtronic, Inc., NuVasive, Inc., Biomet, Inc., Smith & Nephew Plc, Baxter International Inc., Wright Medical Group, Inc. and Stryker Corporation.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

Australia Orthobiologics Market Outlook to 2021
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Orthobiologics Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Orthobiologics Market, Australia 8
3.1 Orthobiologics Market, Australia, Revenue ($m), 2007-2014 8
3.2 Orthobiologics Market, Australia, Revenue ($m), 2014-2021 10
3.2.1 Bone Grafts and Substitutes Market, Australia, Revenue ($m), by Segment, 2007-2014 12
3.2.2 Bone Grafts and Substitutes Market, Australia, Revenue ($m), by Segment, 2014-2021 14
3.3 Orthobiologics Market, Australia, Volume (Units), 2007-2014 16
3.4 Orthobiologics Market, Australia, Volume (Units), 2014-2021 18
3.4.1 Bone Grafts and Substitutes Market, Australia, Volume (Units), by Segment, 2007-2014 20
3.4.2 Bone Grafts and Substitutes Market, Australia, Volume (Units), by Segment, 2014-2021 22
3.5 Orthobiologics Market, Australia, Average Price ($), 2007-2021 24
3.6 Orthobiologics Market, Australia, Distribution Share by Revenue ($m), 2013-2014 26
3.7 Orthobiologics Market, Australia, Company Share by Revenue ($m), 2014 27
4 Overview of Key Companies in Australia, Orthobiologics Market 29
4.1 Medtronic plc 29
4.1.1 Company Overview 29
4.2 Bioventus LLC 29
4.2.1 Company Overview 29
4.3 DePuy Companies 29
4.3.1 Company Overview 29
4.4 Australian Biotechnologies Pty. Limited 29
4.4.1 Company Overview 29
4.5 Cellumed Co. Ltd. 30
4.5.1 Company Overview 30
4.6 Biomet, Inc. (Inactive) 30
4.6.1 Company Overview 30
4.7 Patterson Medical Holdings, Inc. 30
4.7.1 Company Overview 30
4.8 Seikagaku Corporation 30
4.8.1 Company Overview 30
4.9 Baxter International Inc. 31
4.9.1 Company Overview 31
4.10 Sanofi 31
4.10.1 Company Overview 31
4.11 Stryker Corporation 31
4.11.1 Company Overview 31
4.12 Alphatec Holdings, Inc. 32
4.12.1 Company Overview 32
4.13 Arthrex, Inc. 32
4.13.1 Company Overview 32
5 Orthobiologics Market Pipeline Products 33
6 Appendix 37
6.1 Research Methodology 38
6.1.1 Coverage 38
6.1.2 Secondary Research 38
6.1.3 Primary Research 39
6.1.4 Market Modeling and Forecasting 40
6.1.5 Company Share Analysis 43
6.1.6 Distribution Share Analysis 44
6.2 Expert Panel 45
6.3 GlobalData Consulting 45
6.4 Contact Us 45
6.5 Disclaimer 45

1.1 List of Tables
Table 1: Orthobiologics Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 9
Table 2: Orthobiologics Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 11
Table 3: Bone Grafts and Substitutes Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 13
Table 4: Bone Grafts and Substitutes Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 15
Table 5: Orthobiologics Market, Australia, Volume (Units), Historic, 2007-2014 17
Table 6: Orthobiologics Market, Australia, Volume (Units), Forecast, 2014-2021 19
Table 7: Bone Grafts and Substitutes Market, Australia, Volume (Units), Historic, 2007-2014 21
Table 8: Bone Grafts and Substitutes Market, Australia, Volume (Units), Forecast, 2014-2021 23
Table 9: Orthobiologics Market, Australia, Average Price ($), Historic, 2007-2014 24
Table 10: Orthobiologics Market, Australia, Average Price ($), Forecast, 2014-2021 25
Table 11: Orthobiologics Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2013-2014 26
Table 12: Orthobiologics Market, Australia, Company Share by Revenue ($m), USD Constant, 2014 28
Table 13: Orthobiologics Market Pipeline Products 33
Table 14: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country 40

1.2 List of Figures
Figure 1: Orthobiologics Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 8
Figure 2: Orthobiologics Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 10
Figure 3: Bone Grafts and Substitutes Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 12
Figure 4: Bone Grafts and Substitutes Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 14
Figure 5: Orthobiologics Market, Australia, Volume (Units), Historic, 2007-2014 16
Figure 6: Orthobiologics Market, Australia, Volume (Units), Forecast, 2014-2021 18
Figure 7: Bone Grafts and Substitutes Market, Australia, Volume (Units), Historic, 2007-2014 20
Figure 8: Bone Grafts and Substitutes Market, Australia, Volume (Units), Forecast, 2014-2021 22
Figure 9: Orthobiologics Market, Australia, Company Share (%) 2014 27
Figure 10: GlobalData Epidemiology-Based Forecasting Model 42
Figure 11: GlobalData Capital Equipment-Based Forecasting Model 43
Figure 12: Primary Interviews by Participant Type (%) 44

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Dental Membrane and Bone Graft Substitutes Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Dental Membrane and Bone Graft Substitutes Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • November 2016
  • by Transparency Market Research

Dental Membrane and Bone Graft Substitutes Market: Overview Dental membrane and bone graft substitutes is used in the bone graft surgeries. Bone graft surgery is required when tooth is lost by accidents, ...

Bone Morphogenetic Protein Market Analysis By Type (rhBMP-2, rhBMP-7), By Application (Spinal Fusion, Trauma, Reconstruction, Oral Maxillofacial Surgery), By Region And Segment Forecasts, 2013 - 2024

Bone Morphogenetic Protein Market Analysis By Type (rhBMP-2, rhBMP-7), By Application (Spinal Fusion, Trauma, Reconstruction, Oral Maxillofacial Surgery), By Region And Segment Forecasts, 2013 - 2024

  • $ 4950
  • Industry report
  • December 2016
  • by Grand View Research

The global bone morphogenetic protein (BMP) market size is expected to reach over USD 644.6 million by 2024, based on a new report by Grand View Research, Inc. Increasing incidence of spinal fusion, trauma, ...

Orthobiologics Market Analysis By Product (DBM, Allograft, BMP, Viscosupplementation, Synthetic Bone Substitutes, Stem Cell), By Application (Spinal Fusion, Reconstructive Surgery, Trauma Repair), By End Use And Segment Forecasts, 2014 - 2025

Orthobiologics Market Analysis By Product (DBM, Allograft, BMP, Viscosupplementation, Synthetic Bone Substitutes, Stem Cell), By Application (Spinal Fusion, Reconstructive Surgery, Trauma Repair), By End Use And Segment Forecasts, 2014 - 2025

  • $ 4950
  • Industry report
  • January 2017
  • by Grand View Research

The global orthobiologics market is expected to reach USD 10.2 billion by 2025, according to a new study by Grand View Research, Inc. The orthobiologics market is predominantly driven by the increasing ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.